selected publications
- Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults. Frontiers in oncology. 2025 Review GET IT
- Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2. Cell. 2025 Academic Article GET IT
- The Histone Demethylase LSD1/ZNF217/CoREST Complex is a Major Restriction Factor of Epstein-Barr Virus Lytic Reactivation. 2025 GET IT
-
An immunohistochemical atlas of necroptotic pathway expression.
EMBO molecular medicine.
2024
Academic Article
GET IT
Times cited: 12 - Germinal center cytokines driven epigenetic control of Epstein-Barr virus latency gene expression. PLoS pathogens. 2024 Academic Article GET IT
-
Targeting latent viral infection in EBV-associated lymphomas.
Frontiers in immunology.
2024
Review
GET IT
Times cited: 8 - Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression. 2024 GET IT
- Relapsed/Refractory Primary Mediastinal B-cell Lymphoma: Where do we Stand?. Transplantation and cellular therapy. 2023 Academic Article GET IT
- Mature B-cell lymphomas in adolescents and young adults. EJHaem. 2023 Academic Article GET IT
-
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
Pediatric blood & cancer.
2023
Academic Article
GET IT
Times cited: 7 -
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
Pediatric blood & cancer.
2023
Academic Article
GET IT
Times cited: 6 - Pembrolizumab in PMBCL: can it go the distance?. Blood. 2023 Editorial Article GET IT
-
Does congenital cytomegalovirus infection contribute to the development of acute lymphoblastic leukemia in children?.
Current opinion in virology.
2023
Review
GET IT
Times cited: 2 - Brentuximab Vedotin Following Autologous Transplantation in Pediatric Patients with Relapsed/Refractory Hodgkin Lymphoma. Blood advances. 2023 Academic Article GET IT
-
Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
Journal of the National Comprehensive Cancer Network : JNCCN.
2023
Review
GET IT
Times cited: 6 -
Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Best practice & research. Clinical haematology.
2023
Review
GET IT
Times cited: 12 - Molecular evolution of classic Hodgkin lymphoma revealed through whole genome sequencing of Hodgkin and Reed Sternberg cells. Blood cancer discovery. 2023 Academic Article GET IT
-
Methionine metabolism controls the B cell EBV epigenome and viral latency.
Cell metabolism.
2022
Academic Article
GET IT
Times cited: 36 -
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Blood advances.
2022
Academic Article
GET IT
Times cited: 9 - The ABVD's of cooperative trials in pediatric Hodgkin lymphoma: The India experience. Leukemia & lymphoma. 2022 Comment GET IT
-
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.
HemaSphere.
2021
Academic Article
GET IT
Times cited: 13 -
Therapeutic options for CTLA-4 insufficiency.
The Journal of allergy and clinical immunology.
2021
Academic Article
GET IT
Times cited: 85 -
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Blood.
2021
Academic Article
GET IT
Times cited: 21 -
AYA Considerations for Aggressive Lymphomas.
Current hematologic malignancy reports.
2021
Review
GET IT
Times cited: 1 -
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes.
Blood advances.
2020
Academic Article
GET IT
Times cited: 33 -
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.
Blood.
2020
Academic Article
GET IT
Times cited: 45 -
DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression.
Nature microbiology.
2020
Academic Article
GET IT
Times cited: 40 -
MYC Controls the Epstein-Barr Virus Lytic Switch.
Molecular cell.
2020
Academic Article
GET IT
Times cited: 71 -
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.
Blood advances.
2019
Academic Article
GET IT
Times cited: 26 -
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2019
Academic Article
GET IT
Times cited: 122 -
Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses.
International journal of pediatric otorhinolaryngology.
2019
Academic Article
GET IT
Times cited: 1 -
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.
Oncoimmunology.
2018
Academic Article
GET IT
Times cited: 16 -
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers.
Frontiers in immunology.
2018
Academic Article
GET IT
Times cited: 82 -
How I treat primary mediastinal B-cell lymphoma.
Blood.
2018
Review
GET IT
Times cited: 58 -
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
The Journal of allergy and clinical immunology.
2018
Academic Article
GET IT
Times cited: 365 -
Enhancer of zeste homolog 2 (EZH2) inhibitors.
Leukemia & lymphoma.
2018
Information Resource
GET IT
Times cited: 157 -
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.
Leukemia & lymphoma.
2017
Academic Article
GET IT
Times cited: 11 -
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
British journal of haematology.
2017
Academic Article
GET IT
Times cited: 118 -
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
Molecular cancer therapeutics.
2017
Academic Article
GET IT
Times cited: 65 -
CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl.
2017
GET IT
Times cited: 6 -
Management of primary central nervous system lymphoma in children.
Hematology. American Society of Hematology. Education Program.
2016
Review
GET IT
Times cited: 12 -
Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.
British journal of haematology.
2016
Review
GET IT
Times cited: 18 - Reducing radiation exposure in children with febrile neutropenia: can pulmonary MRI replace CT?. Leukemia & lymphoma. 2015 Comment GET IT
-
Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
British journal of haematology.
2015
Review
GET IT
Times cited: 19 -
EZH2: a potential new target in T-cell lymphoma?.
Leukemia & lymphoma.
2015
Comment
GET IT
Times cited: 4 -
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Blood.
2014
Academic Article
GET IT
Times cited: 182 -
Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Pediatric blood & cancer.
2013
Academic Article
GET IT
Times cited: 25 -
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
British journal of haematology.
2013
Academic Article
GET IT
Times cited: 29 -
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.
Blood.
2012
Academic Article
GET IT
Times cited: 90 -
Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease.
British journal of haematology.
2011
Letter
GET IT
Times cited: 9 -
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
Blood.
2011
Academic Article
GET IT
Times cited: 30 -
Treatment with rituximab in benign and malignant hematologic disorders in children.
The Journal of pediatrics.
2007
Review
GET IT
Times cited: 63 -
Update on therapeutic monoclonal antibodies.
Current problems in pediatric and adolescent health care.
2007
Review
GET IT
Times cited: 12 -
Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes.
American journal of obstetrics and gynecology.
2006
Academic Article
GET IT
Times cited: 69 -
Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?.
Journal of child and adolescent psychopharmacology.
2002
Academic Article
GET IT
Times cited: 35